[go: up one dir, main page]

NO20002590L - Formuleringer omfattende oppløst paroxetin - Google Patents

Formuleringer omfattende oppløst paroxetin

Info

Publication number
NO20002590L
NO20002590L NO20002590A NO20002590A NO20002590L NO 20002590 L NO20002590 L NO 20002590L NO 20002590 A NO20002590 A NO 20002590A NO 20002590 A NO20002590 A NO 20002590A NO 20002590 L NO20002590 L NO 20002590L
Authority
NO
Norway
Prior art keywords
paroxetine
solid
formulations
solutions
dissolved
Prior art date
Application number
NO20002590A
Other languages
English (en)
Other versions
NO20002590D0 (no
Inventor
Ahmad Ghazawi
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20002590D0 publication Critical patent/NO20002590D0/no
Publication of NO20002590L publication Critical patent/NO20002590L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives farmasøytiske formuleringer av paroxetin, hvor paroxetinet er i løsning i en fast, halvfast eller flytende bærer. Løsningene benyttes til fylling av kapsler, eller selvbærende faste løsninger formes til faste doseringsformer som tabletter eller pellets. Det beskrives også nye flytende formuleringer, hvor et solubiliseringsmiddel benyttes til å solubilisere paroxetin i oljer og/eller lipider, samt fremgangsmåter for å unngå at andre paroxetinformer omdannes til hemihydratet, ved bruk av vannfrie eller hydrofobe bærere eller hjelpestoffer.
NO20002590A 1997-11-21 2000-05-19 Formuleringer omfattende oppløst paroxetin NO20002590L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine

Publications (2)

Publication Number Publication Date
NO20002590D0 NO20002590D0 (no) 2000-05-19
NO20002590L true NO20002590L (no) 2000-07-19

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002590A NO20002590L (no) 1997-11-21 2000-05-19 Formuleringer omfattende oppløst paroxetin

Country Status (24)

Country Link
EP (1) EP1033986A1 (no)
JP (1) JP2001523718A (no)
KR (1) KR20010032320A (no)
CN (1) CN1279608A (no)
AP (1) AP2000001821A0 (no)
AR (1) AR015485A1 (no)
AU (1) AU1168099A (no)
BG (1) BG104527A (no)
BR (1) BR9814220A (no)
CO (1) CO4970832A1 (no)
DZ (1) DZ2658A1 (no)
EA (1) EA200000552A1 (no)
GB (1) GB9724544D0 (no)
HU (1) HUP0100580A3 (no)
IL (1) IL136106A0 (no)
MA (1) MA24704A1 (no)
NO (1) NO20002590L (no)
OA (1) OA11385A (no)
PE (1) PE20000381A1 (no)
PL (1) PL340555A1 (no)
SK (1) SK7342000A3 (no)
TR (1) TR200001423T2 (no)
WO (1) WO1999026625A1 (no)
ZA (1) ZA9810637B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
EP1161241B1 (de) 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
DE60004768T2 (de) 1999-07-01 2004-07-08 Italfarmaco S.P.A. Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
JP2005531495A (ja) * 2001-12-21 2005-10-20 シャイア ラボラトリーズ，インコーポレイテッド 高い物理的安定性を有する経口カプセル製剤
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
JP2013512948A (ja) * 2009-12-08 2013-04-18 イル・ファ・カンパニー・リミテッド ２０−Ｏ−β−Ｄ−グルコピラノシル−２０（Ｓ）−プロトパナキサジオールを含む固体分散体
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
NZ336587A (en) * 1997-01-15 2001-01-26 Smithkline Beecham P Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran

Also Published As

Publication number Publication date
WO1999026625A1 (en) 1999-06-03
NO20002590D0 (no) 2000-05-19
AR015485A1 (es) 2001-05-02
PE20000381A1 (es) 2000-05-07
GB9724544D0 (en) 1998-01-21
PL340555A1 (en) 2001-02-12
CN1279608A (zh) 2001-01-10
MA24704A1 (fr) 1999-07-01
JP2001523718A (ja) 2001-11-27
BG104527A (en) 2001-04-30
EP1033986A1 (en) 2000-09-13
TR200001423T2 (tr) 2000-10-23
KR20010032320A (ko) 2001-04-16
CO4970832A1 (es) 2000-11-07
SK7342000A3 (en) 2000-12-11
IL136106A0 (en) 2001-05-20
ZA9810637B (en) 2000-05-22
BR9814220A (pt) 2001-12-26
EA200000552A1 (ru) 2000-10-30
DZ2658A1 (fr) 2003-03-22
HUP0100580A3 (en) 2002-05-28
AU1168099A (en) 1999-06-15
HUP0100580A2 (hu) 2002-04-29
AP2000001821A0 (en) 2000-06-30
OA11385A (en) 2004-01-27

Similar Documents

Publication Publication Date Title
ES2191862T3 (es) Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
NO20002590L (no) Formuleringer omfattende oppløst paroxetin
GB2314508A (en) Diamide-dicarboxylic acid microspheres
ATE307569T1 (de) Gelierbare pharmazeutische zusammensetzungen
NO20002133L (no) Oppløsninger og dispersjoner i fast tilstand av svakt vannoppløselige legemidler
ES2196621T3 (es) Sistemas de administracion de farmacos que utilizan estructuras de cristal liquido.
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
DK0501985T3 (da) Uovertrukket farmaceutisk reaktionstablet
UA74339C2 (uk) Форма для введення, що включає інгібітор протонної помпи у вигляді окремих одиниць, та спосіб їх одержання
IS4329A (is) Fjöleiningaskammtar í töfluformi sem innihalda prótónupumpublokkara
ATE215370T1 (de) Selbstemulgierende formulierung enthaltend lipophile verbindungen
DE69940674D1 (de) Orale verabreichung von adenosin analogen
ES8502333A1 (es) Un procedimiento para la preparacion de una tableta farmaceutica
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
DE58902457D1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
ES2029776T1 (es) Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con una alta estabilidad.
SV2002000301A (es) Composicion farmaceutica ref. z-1032
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
ES8402504A1 (es) Procedimiento para preparar capsulas de gelatina blanda de alcaloides del cornezuelo de centeno.
DE3486020D1 (de) Spirotricycloaromatische succinimidderivate als aldose-reduktase-inhibitoren.
KR910011241A (ko) 정제로 직접 압착 가능한 약제학적 분말 조성물을 제조하기 위한 분무 건조법
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
Wiseman et al. The distribution, excretion and metabolism of benzquinamide
DE69416034D1 (de) Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application